Science Corp., a brain-computer interface startup founded by former Neuralink employees, secured $230 million in Series C funding, bringing its total raised to $489 million and valuing it at approximately $1.5 billion. This significant investment underscores the growing interest in neural technology startups, particularly those developing both brain-implant systems and retinal implants for treating eye diseases. For content creators, this highlights a burgeoning tech sector ripe with innovation and funding opportunities in biotech and medical devices.
Read the full article at Crunchbase News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
15
Comments
Ali NematiWritten by Ali
